Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Capsule preparation for external use for preventing and treating vaginitis

A vaginitis and capsule technology, which is applied in the field of biomedicine to achieve the effects of enhancing immunity, repairing vaginal mucosal barrier and inhibiting purulence

Active Publication Date: 2021-08-13
FUJIAN LONGSHENG BIOLOGICAL TECH CO LTD
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, Lactobacillus live bacteria capsules are available for vaginal use, but at the same time, the repair of vaginal mucosa is also extremely important. A complete mucosal barrier provides a guarantee for preventing the recurrence of vaginitis, but the use of Lactobacillus live bacteria capsules alone cannot meet this demand

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Capsule preparation for external use for preventing and treating vaginitis
  • Capsule preparation for external use for preventing and treating vaginitis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Step 1. Weighing: Weigh 1 portion of Lactobacillus plantarum freeze-dried powder according to parts by weight (the number of live Lactobacillus ≥ 1×10 9 CFU), 68 parts of maltodextrin, 30 parts of fructooligosaccharide, 1 part of magnesium stearate;

[0022] Step 2, mixing: the Lactobacillus plantarum freeze-dried powder, maltodextrin, fructooligosaccharides, and magnesium stearate weighed in step 1 are uniformly mixed in equal increments;

[0023] Step 3, capsule filling: take the material mixed in step 2, fill it in gelatin hollow capsules with a capsule filling machine, and the filling dose is 0.25g / capsule, to obtain capsule A;

[0024] Step 4. Weighing: Weigh 75 parts of transdermal EGF freeze-dried powder, 15 parts of transdermal bFGF freeze-dried powder, 5 parts of mannitol, 4 parts of trehalose, and 1 part of magnesium stearate in parts by weight;

[0025] Step 5, mixing: mix the transdermal EGF freeze-dried powder, transdermal bFGF freeze-dried powder, mannito...

Embodiment 2

[0030] Step 1. Weighing: Weigh 1 portion of Lactobacillus plantarum freeze-dried powder according to parts by weight (the number of live Lactobacillus ≥ 1×10 9 CFU), 70 parts of maltodextrin, 27.5 parts of inulin, 1.5 parts of magnesium stearate;

[0031] Step 2, mixing: the Lactobacillus plantarum freeze-dried powder, maltodextrin, inulin, and magnesium stearate weighed in step 1 are uniformly mixed in equal increments;

[0032] Step 3, capsule filling: take the material mixed in step 2, fill it in gelatin hollow capsules with a capsule filling machine, and the filling dose is 0.5g / capsule, to obtain capsule A;

[0033] Step 4. Weighing: Weigh 75 parts of transdermal EGF freeze-dried powder, 15 parts of transdermal bFGF freeze-dried powder, 5 parts of mannitol, 3.5 parts of trehalose, and 1.5 parts of magnesium stearate in parts by weight;

[0034] Step 5, mixing: mix the transdermal EGF freeze-dried powder, transdermal bFGF freeze-dried powder, mannitol, trehalose, and magn...

Embodiment 3

[0039] Step 1. Weighing: Weigh 1 portion of Lactobacillus plantarum freeze-dried powder according to parts by weight (the number of live Lactobacillus ≥ 1×10 9 CFU), 60 parts of maltodextrin, 37 parts of stachyose, 2 parts of magnesium stearate;

[0040] Step 2, mixing: the Lactobacillus plantarum freeze-dried powder, maltodextrin, stachyose, and magnesium stearate weighed in step 1 are uniformly mixed in equal increments;

[0041] Step 3, capsule filling: take the material mixed in step 2, fill it in gelatin hollow capsules with a capsule filling machine, and the filling dose is 1.5g / capsule, to obtain capsule A;

[0042] Step 4, weighing: weigh 75 parts of transdermal EGF freeze-dried powder, 15 parts of transdermal bFGF freeze-dried powder, 5 parts of mannitol, 3 parts of trehalose, and 2 parts of magnesium stearate in parts by weight;

[0043] Step 5, mixing: mix the transdermal EGF freeze-dried powder, transdermal bFGF freeze-dried powder, mannitol, trehalose, and magnes...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an external capsule preparation for preventing and treating vaginitis, which consists of two parts: capsule A and capsule B. Capsule A contains plantaractobacillus ST-III as the main active ingredient, and capsule B contains transdermal EGF, transdermal bFGF is the main active ingredient; in the capsule preparation for external use, the number of live bacteria of Lactobacillus plantarum ST‑Ⅲ should not be less than 0.25×10 6 CFU / capsule, transdermal EGF should not be less than 1000 ng / capsule, and transdermal bFGF should not be less than 200 ng / capsule. The capsule preparation for external use has the functions of enhancing local immunity and repairing the vaginal mucosal barrier, and is worthy of wide application in clinical treatment.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to an external capsule preparation for preventing and treating vaginitis. Background technique [0002] Vaginitis is a general term for a variety of vaginal mucosal inflammatory diseases caused by different etiologies. In normal physiological state, the tissue anatomy and biochemical characteristics of the vagina are sufficient to defend against the invasion of external microorganisms. If it is destroyed, pathogenic bacteria can take advantage of the opportunity to enter and cause vaginal inflammation through various factors. Although vaginitis is a common disease in women, it may cause more serious gynecological diseases and even cancer, so vaginitis must not be underestimated. [0003] Vaginitis can be roughly divided into three categories, namely atrophic vaginitis, irritative vaginitis and infectious vaginitis. Vaginitis in menopausal women with estrogen imbal...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/18A61K9/48A61P15/02A61P31/04A61K31/047A61K31/702A61K31/733A61K35/747
CPCA61K9/4858A61K31/047A61K31/702A61K31/733A61K35/747A61K38/1808A61K38/1825A61P15/02A61P31/04A61K2300/00
Inventor 林冠雄饶照明曾如意朱海仁
Owner FUJIAN LONGSHENG BIOLOGICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com